• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 12, 2017

View Archived Issues

Anti-CD73 A-001421 shows antitumor activity in experimental tumor models

Read More

Novel technique of rapid and robust diagnosis of Alzheimer's disease and various other dementias

Read More

TargomiRs demonstrates early signs of activity in patients with malignant pleural mesothelioma

Read More

Phase III trial of upadacitinib in rheumatoid arthritis meets all endpoints

Read More

Infant Bacterial Therapeutics reports topline safety data from phase II study of IBP-9414

Read More

MK-3866 studied in patients with impaired renal function

Read More

DelMar Pharmaceuticals commences phase II study of VAL-083 in GBM

Read More

EMA grants orphan drug designation to seladelpar for primary biliary cholangitis

Read More

New oncolytic measles virus-mediated delivery of PD-1-targeting antibody for cancer treatment

Read More

Marinus Pharmaceuticals reports results from phase II study in CDKL5 disorder

Read More

BARDA awards contract to Summit Therapeutics to develop ridinilazole for CDI

Read More

GSK initiates phase I study of acute pancreatitis treatment GSK-3335065

Read More

2017 Lasker awards recognize significance of HPV vaccine, mTOR

Read More

East China University of Science and Technology patents EGFR inhibitors

Read More

Taiho Pharmaceutical identifies RET inhibitors

Read More

DiaMedica Therapeutics begins phase II study of DM-199

Read More

Cantargia initiates phase I/II trial of CAN-04 in solid malignant tumors

Read More

DENV glycoprotein EDIII variants reported in Albert Einstein College of Medicine patent

Read More

Merck KGaA compares MSB-11455 to Neulasta in phase I studies

Read More

Global Alliance for TB Drug Development initiates phase I study of TBA-7371

Read More

Phase III LIBERTY ASTHMA QUEST study of dupilumab meets primary endpoints

Read More

The Osaka University discloses reoviruses for treating fibrosis

Read More

New phase I trial evaluates M-3541 with radiotherapy in patients with solid tumors

Read More

Bayer enters kidney disease collaboration with Vanderbilt University Medical Center

Read More

New malaria trial explores modifications to vaccine regimen of RTS,S

Read More

HitGen and Takeda establish drug discovery research collaboration

Read More

Canalia launched in Japan for type 2 diabetes

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe